Emzotamig
Emzotamig is a monoclonal antibody inhibitor targeting tumor necrosis factor (TNF). Emzotamig is promising for research of autoimmune diseases associated with TNF overexpression, such as rheumatoid arthritis and ankylosing spondylitis.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 3037572-57-6
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Ver todos los productos específicos de isoformas TNF Receptor
More
Actividad biológica
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
Human
TNFRSF17 & NCR1
Unconjugated
The product can be reconstituted/diluted with sterile PBS or saline.
-
VH-VH-CH1_VL-L-kappa_h-CH2-CH3
ELISA, FACS, Functional assay
Chemical Information
-
No. CAS 3037572-57-6
-
SMILES
N/A
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)